On Friday, in the course of current trade, Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO), dropped -1.40%, and is now trading at $ 20.45.
Halozyme Therapeutics, declared its chief financial officer David Ramsay will retire this summer, and named biotech veteran Laurie Stelzer as his successor. Stelzer will assume CFO duties on June 15 and will work with Ramsay through a transition period.
“Since last year, David and I have been working closely to plan for his eventual retirement and I am thrilled to now welcome a finance executive of Laurie’s caliber,” said Dr. Helen Torley, president and chief executive officer. “David assisted guide Halozyme for more than a decade as the company built a noteworthy partner model with our ENHANZE platform and more recently as we laid the foundation for the development of our oncology programs. I want to thank him for the value he has created for our employees and shareholders, and for being a trusted partner to me.
Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other drugs or can be used to alter abnormal tissue structures for clinical benefit.
During an Afternoon trade, Shares of Lexington Realty Trust (NYSE:LXP), dipped - 0.11%, and is now trading at $ 8.97.
Lexington Realty Trust, declared that it sold an office property in Orlando, Florida for gross proceeds of about $64.7 million. The 358,381 square foot office building was constructed in 1984 and leased to a single tenant for 25 years. In 2009, the tenant vacated the building and Lexington redeveloped the property and leased it to several tenants.
T. Wilson Eglin, Lexington’s Chief Executive Officer, commented “This disposition completes our successful repositioning of an asset that had been vacant following the expiration of a single-tenant lease. The re-leasing of this property to about 100% occupancy represents an important component of our asset administration and capital recycling strategy, which is designed to maximize the value of our multi-tenanted properties and create liquidity for investments in single-tenant properties subject to long-term leases.”
Lexington Corporate Properties Trust operates as a self-managed and self-administered real estate investment trust (REIT). The company acquires, owns, and manages a portfolio of office, industrial, and retail properties net-leased to corporate tenants in the United States.
Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), during its Friday’s current trading session raised 0.54%, and is now trading at $ 169.75.
Alexion Pharmaceuticals, declared that the U.S. Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Alexion’s pending acquisition of Synageva. The waiting period was planned to expire on June 15, 2015.
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease.
Finally, Tenet Healthcare Corp (NYSE:THC), lost -1.50% Friday, hitting its highest level.
Tenet Healthcare Corp, declared that Dartmouth-Hitchcock Health (D-HH), based in Lebanon, New Hampshire, has chosen Conifer Health as its provider for end-to-end revenue cycle administration (RCM) services for hospital and physician services across the health system.
D-HH, which comprises an academic medical center and a multispecialty physician group practice, selected Conifer Health as its transformational partner to manage their patient access, health information administration, reimbursement and patient financial services. Conifer Health’s industry leading solutions will allow D-HH to enhance patient engagement and revenue capture, reduce denials and improve overall cash flow and operating margins.
Tenet Healthcare Corporation, a healthcare services company, primarily operates acute care hospitals and related healthcare facilities in the United States. It operates through two segments, Hospital Operations and Other, and Conifer.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
